A non-randomized, open label clinical trial evaluating the safety and effectiveness of DermaBind TL, a tri-layer dehydrated human placental membrane allograft, in the management of hard-to-heal wounds.
Full study details and results will be published here as they become available. For more information about participating sites or study data, please contact a HealthTech specialist.
